Oklo (NYSE: OKLO) insider files to sell 655,000 Class A shares
Rhea-AI Filing Summary
Oklo, Inc. (OKLO) has a planned insider sale of Class A common stock. A shareholder filed a notice to sell 655,000 Class A shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $62,618,000. The approximate sale date disclosed is January 7, 2026, and the filing notes that 156,247,075 shares of this class were outstanding.
The securities to be sold include 235,000 shares acquired by transfer on March 27, 2025 from Jacob DeWitte, who originally received founder shares on December 31, 2013, and an additional 420,000 founder shares acquired on that 2013 date. Over the prior three months, the filing lists separate sales by Jacob DeWitte and Caroline Cochran, each selling Class A shares on December 22, 2025 and January 5, 2026, with individual transactions of 420,000 and 100,000 shares and disclosed gross proceeds for each sale.
Positive
- None.
Negative
- None.
FAQ
What insider sale does the Oklo (OKLO) Form 144 disclose?
The notice discloses a planned sale of 655,000 Oklo Class A common shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of
When is the planned sale of Oklo (OKLO) shares expected to occur?
The Form 144 states an approximate sale date of January 7, 2026 for the 655,000 Class A common shares.
How many Oklo (OKLO) Class A shares are outstanding in this Form 144?
The filing reports that 156,247,075 Class A common shares were outstanding as of the time referenced in the notice.
How were the Oklo (OKLO) shares in this Form 144 originally acquired?
The securities to be sold include 235,000 shares acquired by transfer on
What recent Oklo (OKLO) insider sales are listed in the past 3 months?
The notice lists sales by Jacob DeWitte and Caroline Cochran of Class A common stock: each sold 420,000 shares on
Which broker is handling the Oklo (OKLO) Form 144 share sale?
The planned sale of 655,000 Oklo Class A shares will be handled by J.P. Morgan Securities LLC, located at 270 Park Avenue, New York, NY 10017.